作者
Ra'ed Jabr, Akshay Khatri, Anthony D Anderson, Leopoldo Cordova Garcia, Julia Bini Viotti, Yoichiro Natori, Mohammed Raja, Jose F Camargo, Michele I Morris
发表日期
2023/2
期刊
Transplant Infectious Disease
卷号
25
期号
1
页码范围
e14006
简介
Background
Data on severe acute respiratory distress syndrome coronavirus 2 monoclonal antibody (SARS‐CoV‐2‐specific mAb) use in hematologic malignancy and hematopoietic cell transplantation (HM/HCT) patients are limited. Here, we describe our experience with the use of casirivimab–imdevimab or bamlanivimab for the treatment of coronavirus disease 2019 (COVID‐19) in HM/HCT patients.
Methods
This was a retrospective chart review at the University of Miami Hospital and Sylvester Comprehensive Cancer Center for HM/HCT patients with COVID‐19 who received casirivimab–imdevimab or bamlanivimab from November 21, 2020, to September 30, 2021. Outcomes measured were mortality, hospital admission, and infusion reaction to SARS‐CoV‐2‐specific mAbs.
Results
We identified 59 HM/HCT patients with mild to moderate COVID‐19 who received casirivimab–imdevimab or bamlanivimab …
学术搜索中的文章
R Jabr, A Khatri, AD Anderson, LC Garcia, JB Viotti… - Transplant Infectious Disease, 2023